Journal: The Journal of Molecular Diagnostics : JMD
Article Title: Improving Specificity for Ovarian Cancer Screening Using a Novel Extracellular Vesicle–Based Blood Test
doi: 10.1016/j.jmoldx.2024.09.001
Figure Lengend Snippet: OC Test and CA125 enzyme-linked immunosorbent assay performance in healthy controls and in ovarian cancers. A and C: Training study EDTA plasma samples are shown. B and D : The verification study serum samples are shown. The cutoff set between healthy controls and OC cases is shown as a red dotted line in each graph. HGSC, high-grade serous carcinoma; LGSC, low-grade serous carcinoma.
Article Snippet: The Human CA125/MUC16 Quantikine enzyme-linked immunosorbent assay (ELISA) kit (catalog number DCA 125; R&D Systems, Minneapolis, MN) was used to measure the CA125 level in all EDTA plasma and serum samples.
Techniques: Enzyme-linked Immunosorbent Assay